Discover open access scientific publications

Search, annotate, share and cite publications

Publications by VB Conceição

Pnd119 - Survey Analysis of Treatment With Interferon Beta 1a in Brazil Among Ms Patients Participating in a Patient Support Program (Psp)

Value in Health

English

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

English

Related publications

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Journal of Negative Results in BioMedicine

English

Treatment With Interferon Beta-1a in Brazil Is Associated With Fewer Hospitalizations Due to Relapse, Better Adherence and a Better Response Compared to Other Platform Therapies

English

Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a

Journal of pharmacology & clinical research

2017

English

Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

English

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Multiple Sclerosis

Neurology

2011

English

Interferon Beta-1a for the Maintenance of Remission in Patients With Crohn's Disease: Results of a Phase II Dose-Finding Study

English

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Australian and New Zealand Journal of Medicine

2000

English

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by VB Conceição

Pnd119 - Survey Analysis of Treatment With Interferon Beta 1a in Brazil Among Ms Patients Participating in a Patient Support Program (Psp)

Prm89 - Database Analysis of a PSP (Patient Support Program) for Patients Using Interferon Beta-1a for Relapsing Multiple Sclerosis in Brazil

Related publications

Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a

Treatment With Interferon Beta-1a in Brazil Is Associated With Fewer Hospitalizations Due to Relapse, Better Adherence and a Better Response Compared to Other Platform Therapies

Daclizumab Is More Effective in Reducing Relapse Rates in Multiple Sclerosis Patients Than Interferon Beta-1a

Cost-Utility Analyses of Natalizumab Versus Interferon Beta-1a 44 MCG for Rapidly Evolving Severe Relapsing-Remitting Multiple Sclerosis (RESRRMS) Patients in Brazil

Pregnancy Outcomes in Multiple Sclerosis Following Subcutaneous Interferon Beta-1a Therapy

Interferon Beta-1a for the Maintenance of Remission in Patients With Crohn's Disease: Results of a Phase II Dose-Finding Study

Autoimmune Hypothyroidism Associated With Interferon Beta-1b Treatment in Two Patients With Multiple Sclerosis

Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated With Interferon Beta 1a by 1h-NMR Spectroscopy